vs
Side-by-side financial comparison of Fresenius Medical Care AG (FMS) and TELUS CORP (TU). Click either name above to swap in a different company.
Fresenius Medical Care AG is the larger business by last-quarter revenue ($5.5B vs $3.7B, roughly 1.5× TELUS CORP). Fresenius Medical Care AG runs the higher net margin — 7.9% vs -4.8%, a 12.8% gap on every dollar of revenue. On growth, TELUS CORP posted the faster year-over-year revenue change (2.2% vs -0.3%).
Fresenius Medical Care AG & Co. KGaA is a German healthcare company which provides kidney dialysis services through a network of 4,171 outpatient dialysis centers, serving 345,425 patients. The company primarily treats end-stage renal disease (ESRD), which requires patients to undergo dialysis 3 times per week for the rest of their lives.
TELUS CORPTUEarnings & Financial Report
Telus Corporation is a Canadian publicly traded holding company and conglomerate, headquartered in Vancouver, British Columbia, which is the parent company of several subsidiaries: Telus Communications offers telephony, television, data and Internet services; Telus Mobility offers wireless services; Telus Health operates companies that provide health products and services; and Telus Digital operates worldwide, providing multilingual customer service outsourcing and digital IT services. Telus ...
FMS vs TU — Head-to-Head
Income Statement — Q4 FY2025 vs Q2 FY2025
| Metric | | |
|---|---|---|
| Revenue | $5.5B | $3.7B |
| Net Profit | $434.2M | $-178.8M |
| Gross Margin | 27.4% | 90.2% |
| Operating Margin | 11.7% | 3.4% |
| Net Margin | 7.9% | -4.8% |
| Revenue YoY | -0.3% | 2.2% |
| Net Profit YoY | 240.4% | -210.9% |
| EPS (diluted) | — | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $5.5B | — | ||
| Q2 25 | — | $3.7B | ||
| Q4 24 | $5.5B | — | ||
| Q2 24 | — | $3.6B |
| Q4 25 | $434.2M | — | ||
| Q2 25 | — | $-178.8M | ||
| Q4 24 | $127.6M | — | ||
| Q2 24 | — | $161.3M |
| Q4 25 | 27.4% | — | ||
| Q2 25 | — | 90.2% | ||
| Q4 24 | 25.0% | — | ||
| Q2 24 | — | 87.9% |
| Q4 25 | 11.7% | — | ||
| Q2 25 | — | 3.4% | ||
| Q4 24 | 5.1% | — | ||
| Q2 24 | — | 13.7% |
| Q4 25 | 7.9% | — | ||
| Q2 25 | — | -4.8% | ||
| Q4 24 | 2.3% | — | ||
| Q2 24 | — | 4.4% |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.7B | $2.7B |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $15.4B | $11.8B |
| Total Assets | $33.5B | $44.3B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $1.7B | — | ||
| Q2 25 | — | $2.7B | ||
| Q4 24 | $1.3B | — | ||
| Q2 24 | — | $676.7M |
| Q4 25 | $15.4B | — | ||
| Q2 25 | — | $11.8B | ||
| Q4 24 | $17.0B | — | ||
| Q2 24 | — | $12.4B |
| Q4 25 | $33.5B | — | ||
| Q2 25 | — | $44.3B | ||
| Q4 24 | $36.3B | — | ||
| Q2 24 | — | $41.8B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $2.9B | $851.2M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | 6.67× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $2.9B | — | ||
| Q2 25 | — | $851.2M | ||
| Q4 24 | $2.6B | — | ||
| Q2 24 | — | $1.0B |
| Q4 25 | 6.67× | — | ||
| Q2 25 | — | — | ||
| Q4 24 | 20.20× | — | ||
| Q2 24 | — | 6.28× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
